Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Streptococcus pyogenes Impetigo, Erysipelas, and Cellulitis

Dennis L. Stevens  1 , Amy E. Bryant  2
Joseph J. Ferretti  1 , Dennis L. Stevens  2 , Vincent A. Fischetti  3
, editors.
In: Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 23.
[updated ].
Affiliations
Free Books & Documents
Review

Streptococcus pyogenes Impetigo, Erysipelas, and Cellulitis

Dennis L. Stevens et al.
Free Books & Documents

Excerpt

Streptococcus pyogenes (group A Streptococcus) is one of the most important bacterial causes of skin and soft tissue infections (SSTIs) worldwide. In addition, no other pathogen causes as many diverse clinical entities as S. pyogenes. Specifically, this organism causes infections in the superficial keratin layer (impetigo), the superficial epidermis (erysipelas), the subcutaneous tissue (cellulitis), the fascia (necrotizing fasciitis), or muscle (myositis and myonecrosis). It is also the etiologic agent of scarlet fever and Streptococcal Toxic Shock Syndrome (StrepTSS). Impetigo is a non-life-threatening infection, but can result in post-streptococcal acute glomerulonephritis (AGN). Cellulitis and erysipelas can be mild or moderately severe, while necrotizing fasciitis, myonecrosis and StrepTSS are life-threatening. This chapter focuses on the clinical and epidemiological features of these infections, as well as treatment options, and includes a discussion of bacterial pathogenesis.

PubMed Disclaimer

References

    1. Abrahamian F. M., Sakoulas G., Tzanis E., Manley A., Steenbergen J., Das A. F., et al. McGovern P. C. Omadacycline for acute bacterial skin and skin structure infections. Clinical Infectious Diseases. 2019 August 1;69 Suppl 1:S23–S32. - PMC - PubMed
    1. Adams B. B. Dermatologic disorders of the athlete. Sports Medicine. 2002;32(5):309–321. - PubMed
    1. Alouf, J. E., & Geoffroy, C. (1999). The Family of the Antigenically-Related, Cholesterol-Binding ("Sulphydryl-Activated") Cytolytic Toxins. In J. E. Alouf, & J. H. Freer (Eds.), The Comprehensive Sourcebook of Bacterial Protein Toxins, Second Edition (pp. 147-186). New York: Academic Press.
    1. Anthony B. F., Kaplan E. L., Wannamaker L. W., Chapman S. S. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. American Journal of Epidemiology. 1976;104(6):652–666. - PubMed
    1. Baddour L. M., Bisno A. L. Recurrent cellulitis after saphenous venectomy for coronary bypass surgery. Annals of Internal Medicine. 1982;97(4):493–496. - PubMed

LinkOut - more resources